Found: 4
Select item for more details and to access through your institution.
Real‐world experience of axicabtagene ciloleucel, a CD19‐directed CAR T‐cell therapy, in the second‐line treatment of early relapsed or primary refractory large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 368, doi. 10.1111/bjh.19521
- By:
- Publication type:
- Article
Predictive Factors for Early Relapse in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplant.
- Published in:
- Permanente Journal, 2019, v. 23, n. 4, p. 11, doi. 10.7812/TPP/19.012
- By:
- Publication type:
- Article
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1680, doi. 10.1002/ajh.27378
- By:
- Publication type:
- Article
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1636, doi. 10.1002/ajh.27365
- By:
- Publication type:
- Article